DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

At DICE, we are expecting more out of medicine. We design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. Through combining innovative chemistry with well-validated biology, our goal is to make medicines more accessible and unlock the potential of oral medicines.

Our team is led by an exceptional group of scientists, R&D executives and company builders with demonstrated track records of progressing programs from discovery through regulatory approval and commercialization. Together, we’re building a team that has a passion for innovation and extensive experience in small molecule drug discovery and development.

Find DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company employees' phone numbers or email addresses

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Global Highlights

Location
Employees

North America
30

Minus sign iconPlus sign icon
  • United States Of America
    30

Africa
3

Minus sign iconPlus sign icon
  • Egypt
    2
  • Uganda
    1

Europe
3

Minus sign iconPlus sign icon
  • Germany
    1
  • Netherlands
    1
  • France
    1

Asia
2

Minus sign iconPlus sign icon
  • India
    2

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's Leadership

  • Stylized image of a person
    J. R.
    President
    Phone icon
  • Stylized image of a person
    B. J.
    Founder Board Chairman
    Phone icon
  • Stylized image of a person
    O. Y.
    Vice President, Finance
    Phone icon
  • Stylized image of a person
    L. E.
    Controller
    Phone icon
  • Stylized image of a person
    L. E.
    Controller
    Phone icon
  • Stylized image of a person
    D. W.
    Manager, Document Specialist
    Phone icon
  • Stylized image of a person
    A. M.
    Biosample Manager, Development Sciences
    Phone icon
  • Stylized image of a person
    A. J.
    Senior Accounting Manager
    Phone icon

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Employee Metrics

100%
50%
0%
2026
2025
  • Administrative
  • Biotechnology
  • Business
  • Branding
  • Human Resources
  • Other
  • Analytics

Contact profiles from DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    B. J.
    Founder Board Chairman
    Phone icon
    UNITED STATES
    Aug 04, 2023
  • Stylized image of a person
    J. R.
    President
    Phone icon
    Oct 16, 2024
  • Stylized image of a person
    O. Y.
    Vice President, Finance
    Phone icon
    UNITED STATES
    May 26, 2026
  • Stylized image of a person
    L. E.
    Controller
    Phone icon
    May 02, 2024
  • Stylized image of a person
    L. E.
    Controller
    Phone icon
    Oct 23, 2024
  • Stylized image of a person
    D. W.
    Manager, Document Specialist
    Phone icon
    United States
    May 31, 2026
  • Stylized image of a person
    A. M.
    Biosample Manager, Development Sciences
    Phone icon
    United StatesMassachusetts
    Nov 13, 2025
  • Stylized image of a person
    A. J.
    Senior Accounting Manager
    Phone icon
    United StatesFlorida
    Jul 17, 2025
  • Stylized image of a person
    D. W.
    Senior Document Specialist
    Phone icon
    Oct 17, 2024

Frequently Asked Questions

What is DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company known for?

Minus sign iconPlus sign icon
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company was founded in 2013 operates in the Biotechnology Research industry. The company's main headquarters is located in 279 East Grand Avenue South San Francisco, California 94080 United States; you can contact the main corporate office by phone at . Explore DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's company overview page for more information.

What is DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's most common email format?

Minus sign iconPlus sign icon
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company email formats with LeadIQ.

How many employees does DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company have currently?

Minus sign iconPlus sign icon
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company has approximately 67 employees as of May 2026. These team members are located across 4 continents, including North AmericaAfricaEurope.

Who are DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's key employees and leadership?

Minus sign iconPlus sign icon

As of May 2026, DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's key employees include:

  • President: J. R.
  • Founder Board Chairman: B. J.
  • Vice President, Finance: O. Y.
  • Controller: L. E.
  • Controller: L. E.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.